Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemotherapy Associated Neutropenia|Breast Cancer
Interventions: DRUG: EP2006|DRUG: Filgrastim
Sponsor: Sandoz